3 research outputs found

    Soil arching and load transfer mechanism for slope stabilized with piles

    Get PDF
    In this study, the effects of pile spacing and pile head fixity on the moment and lateral soil pressure distribution along slope stabilizing piles are investigated. A slice from an infinitely long row of piles with fixed pile tip in an inclined sand bed was simulated with an experimental test setup. Surficial soil displacements were monitored and relative displacements between soil particles were determined by recording time-lapse images during the test in order to observe the soil arching mechanism on the soil surface. The load transfer process from moving soil to piles and behavior of soil around piles were observed and evaluated by the different test setups. It was observed that decrease in pile spacing causes an increase of load carried per pile. This behavior, which was significantly influenced by the pile head boundary conditions, can only be explained by soil arching that existed between the piles along their lengths

    The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction

    No full text
    This study was performed to evaluate the relationship between the CHA(2)DS(2)-VASc score and no-reflow (NR) phenomena in patients with non-ST-segment elevation myocardial infarction (NSTEMI). A total number of 428 consecutive patients with NSTEMI were assessed for this study. Patients were divided into 2 groups, those with NR, NR(+) (n=84), and those without NR, NR(-) (n=307), according to their post-PCI, no-reflow status. The CHA(2)DS(2)-VASc score was significantly higher in the NR(+) group compared to the NR(-) (3.48 +/- 1.19 vs 1.81 +/- 0.82,P< 0.001). After a multivariate regression analysis, a higher CHA(2)DS(2)-VASc score (OR: 6.52, 95% CI: 3.51-12.14,P< 0.001), hs-Troponin (OR: 1.077, 95% CI: 1.056-1.099,P<0.001) and TTG (OR: 1.563, 95% CI: 1.134-2.154,P=0.006) were independent predictors of NR. CHA(2)DS(2)-VASc score is associated with higher risk of no-reflow in patients with NSTEMI undergoing PCI
    corecore